Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00465673
What this trial is testing

Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Testing effectiveness (Phase 2)Ended earlyNCT02753595
What this trial is testing

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Eisai Inc. 25
Large-scale testing (Phase 3)Study completedNCT00002777
What this trial is testing

Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 342
Not applicableStudy completedNCT00905281
What this trial is testing

Study of Impact of Routine "Clinical Cancer Department/Supportive Care Department" Consultation on the Prescription of an Additional Line of Chemotherapy

Who this might be right for
Metastatic Breast Cancer
Centre Leon Berard 100
Testing effectiveness (Phase 2)Study completedNCT00054028
What this trial is testing

Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IIIB Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT00505271
What this trial is testing

Safety and Efficacy Study Using Rexin-G for Breast Cancer

Who this might be right for
Breast Cancer
Epeius Biotechnologies 20
Testing effectiveness (Phase 2)UnknownNCT03204734
What this trial is testing

Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 132
Not applicableStudy completedNCT07418411
What this trial is testing

Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer

Who this might be right for
Breast CancerAxillary Lymph Node Metastasis
Institute of Oncology Ljubljana 180
Not applicableStudy completedNCT05905939
What this trial is testing

HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

Who this might be right for
Breast Cancer
AstraZeneca 774
Early research (Phase 1)UnknownNCT05628870
What this trial is testing

A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer

Who this might be right for
Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 102
Testing effectiveness (Phase 2)Study completedNCT01565083
What this trial is testing

Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 213
Testing effectiveness (Phase 2)WithdrawnNCT03065712
What this trial is testing

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT00003539
What this trial is testing

Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)Study completedNCT03955939
What this trial is testing

LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 5
Testing effectiveness (Phase 2)UnknownNCT04745975
What this trial is testing

Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT04563507
What this trial is testing

Combined Immunotherapies in Metastatic ER+ Breast Cancer

Who this might be right for
Breast Cancer
Weill Medical College of Cornell University 102
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Large-scale testing (Phase 3)Study completedNCT00333775
What this trial is testing

Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 736
Early research (Phase 1)Study completedNCT01640665
What this trial is testing

Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors

Who this might be right for
Metastatic Breast CancerGastrointestinal Tumors
Yale University 24
Next Page